Samuel M. Rubinstein
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- COVID-19 and healthcare impacts
- CAR-T cell therapy research
- Health Informatics top 10%
Papers in
- Hematology 12
- Multiple Myeloma Research and Treatments 9
- Oncology 14
- COVID-19 and healthcare impacts 6
- Cancer Treatment and Pharmacology 3
- Co-authors
- Jeremy Lyle Warner (11 shared papers)Douglas Buckner Johnson (2 shared papers)Ellen Kim (1 shared paper)Kevin Thomas Nead (1 shared paper)Andrzej Pawel Wojcieszynski (1 shared paper)Peter Edward Gabriel (1 shared paper)Allison Betof Warner (1 shared paper)Ryan David Nipp (1 shared paper)
- Journals
- Blood (5 papers)JAMA Oncology (3 papers)JCO Clinical Cancer Informatics (3 papers)JAMA Network Open (3 papers)Journal of Geriatric Oncology (3 papers)
- Partner nations
- United StatesAustraliaPoland
In The Last Decade
Samuel M. Rubinstein
47 papers receiving 1.5k citations
Samuel M. Rubinstein's Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 637
- Health Informatics 16
- Hematology 110
- Immunology 192
- Infectious Diseases 157
Countries citing papers authored by Samuel M. Rubinstein
This map shows the geographic impact of Samuel M. Rubinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel M. Rubinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel M. Rubinstein more than expected).
Fields of papers citing papers by Samuel M. Rubinstein
This network shows the impact of papers produced by Samuel M. Rubinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel M. Rubinstein. The network helps show where Samuel M. Rubinstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Samuel M. Rubinstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis Hit paper breakdown → | 2018 | 550 |
| 2 | 2017 | 165 | |
| 3 | 2021 | 141 | |
| 4 | 2019 | 116 | |
| 5 | 2013 | 54 | |
| 6 | 2016 | 51 | |
| 7 | 2020 | 49 | |
| 8 | 2022 | 47 | |
| 9 | 2020 | 40 | |
| 10 | 2018 | 34 | |
| 11 | 2017 | 31 | |
| 12 | 2022 | 31 | |
| 13 | 2023 | 28 | |
| 14 | 2020 | 23 | |
| 15 | 2017 | 18 | |
| 16 | 2021 | 18 | |
| 17 | 2019 | 16 | |
| 18 | 2016 | 15 | |
| 19 | 2022 | 9 | |
| 20 | 2020 | 8 |
About Samuel M. Rubinstein
Samuel M. Rubinstein is a scholar working on Hematology, Oncology, Genetics, Statistics, Probability and Uncertainty and Radiology, Nuclear Medicine and Imaging, having authored 49 papers that have together received 1.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (9 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), COVID-19 and healthcare impacts (6 papers), Cancer Treatment and Pharmacology (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Meta-analysis and systematic reviews (2 papers), Cancer-related cognitive impairment studies (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (637 citations), Health Informatics (16 citations), Hematology (110 citations), Immunology (192 citations) and Infectious Diseases (157 citations). Samuel M. Rubinstein has collaborated with scholars based in United States, Australia and Poland. Frequent co-authors include Jeremy Lyle Warner, Douglas Buckner Johnson, Ellen Kim, Kevin Thomas Nead, Andrzej Pawel Wojcieszynski, Peter Edward Gabriel, Allison Betof Warner, Ryan David Nipp, Krista M. Rubin and Ryan Joseph Sullivan. Their work appears in journals such as Blood, JAMA Oncology, JCO Clinical Cancer Informatics, JAMA Network Open and Journal of Geriatric Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.